Abstract
Neonatal inflammation is common and disrupts adult respiratory control, yet the mechanism(s) underlying the impairments are not well understood. Since microglia are key mediators of central inflammation and are important in the lasting effects of neonatal inflammation in non‐respiratory brain regions, we hypothesized lasting dysfunction in microglia underlie impairments in adult respiratory control. Specifically, we hypothesized neonatal inflammation would increase the number of and inflammatory gene expression in adult microglia. Since adult respiratory motor plasticity in the cervical spinal cord is impaired after neonatal inflammation, we analyzed immunomagnetically isolated microglia from the ventral cervical spinal cord. Interestingly, the number of microglia measured by flow cytometry calibrated with counting beads from adults after neonatal inflammation (LPS; 1 mg/kg, i.p.; postnatal day 4) were unchanged in males (LPS: 14,488 ± 4000, n=4; saline: 12,784 ± 4000, n=4, p=0.97) or females (LPS: 14,611 ± 4500, n=4; saline: 9,062 ± 4500, n=5, p=0.79). Additionally, the number of microglia was not significantly different between males and females (p>0.05). Despite no changes in microglia number, we hypothesized microglia function was impaired by neonatal inflammation. Preliminary transcriptomic analysis suggests neonatal inflammation in adult females (n=2) up‐regulated 7 genes and down‐regulated 1 gene, and in adult males (n=3) down‐regulated 1 gene. Gene ontology revealed these differentially expressed genes are associated with inflammatory signaling. While neonatal inflammation has no impact on the number of microglia, it sex‐dependently increases inflammatory‐related gene expression in females with surprisingly few changes in adult males. Thus, adult, female microglia likely contribute to the lasting impairments in respiratory control following neonatal inflammation. Further, the lasting impairments in adult males are likely mediated by a sex‐specific distinct mechanism. Understanding the sex‐specific inflammatory mechanisms impairing respiratory control is crucial to developing treatment strategies to promote breathing during ventilatory control disorders.Support or Funding InformationSupported by NIH HL141249 (AGH)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.